Cargando…
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
Background: Parkinson's disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305582/ https://www.ncbi.nlm.nih.gov/pubmed/30619041 http://dx.doi.org/10.3389/fneur.2018.01081 |
_version_ | 1783382597932417024 |
---|---|
author | Schröder, Jens B. Pawlowski, Matthias Meyer zu Hörste, Gerd Gross, Catharina C. Wiendl, Heinz Meuth, Sven G. Ruck, Tobias Warnecke, Tobias |
author_facet | Schröder, Jens B. Pawlowski, Matthias Meyer zu Hörste, Gerd Gross, Catharina C. Wiendl, Heinz Meuth, Sven G. Ruck, Tobias Warnecke, Tobias |
author_sort | Schröder, Jens B. |
collection | PubMed |
description | Background: Parkinson's disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood (PB) of PD patients. Ten PD patients were diagnosed according to brain bank criteria and underwent detailed clinical examination, magnetic resonance imaging, PB and CSF immune cell profiling by multiparameter flow cytometry, and cytokine and chemokine measurements by bead-based arrays. Thirteen healthy elderly volunteers served as control population. Results: The proportions of activated T-lymphocytes and non-classical monocytes in the CSF were increased in patients with PD compared to the control group. In accordance, we found increased levels of the pro-inflammatory cytokines IL-2, IL-6 and TNFα and of the monocyte chemoattractant protein 1 (MCP-1) in the CSF of the included PD patients. Conclusions: Our data provide novel evidence for a response of the innate and adaptive immune system in the central nervous system of patients with PD. |
format | Online Article Text |
id | pubmed-6305582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63055822019-01-07 Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease Schröder, Jens B. Pawlowski, Matthias Meyer zu Hörste, Gerd Gross, Catharina C. Wiendl, Heinz Meuth, Sven G. Ruck, Tobias Warnecke, Tobias Front Neurol Neurology Background: Parkinson's disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood (PB) of PD patients. Ten PD patients were diagnosed according to brain bank criteria and underwent detailed clinical examination, magnetic resonance imaging, PB and CSF immune cell profiling by multiparameter flow cytometry, and cytokine and chemokine measurements by bead-based arrays. Thirteen healthy elderly volunteers served as control population. Results: The proportions of activated T-lymphocytes and non-classical monocytes in the CSF were increased in patients with PD compared to the control group. In accordance, we found increased levels of the pro-inflammatory cytokines IL-2, IL-6 and TNFα and of the monocyte chemoattractant protein 1 (MCP-1) in the CSF of the included PD patients. Conclusions: Our data provide novel evidence for a response of the innate and adaptive immune system in the central nervous system of patients with PD. Frontiers Media S.A. 2018-12-18 /pmc/articles/PMC6305582/ /pubmed/30619041 http://dx.doi.org/10.3389/fneur.2018.01081 Text en Copyright © 2018 Schröder, Pawlowski, Meyer zu Hörste, Gross, Wiendl, Meuth, Ruck and Warnecke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Schröder, Jens B. Pawlowski, Matthias Meyer zu Hörste, Gerd Gross, Catharina C. Wiendl, Heinz Meuth, Sven G. Ruck, Tobias Warnecke, Tobias Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease |
title | Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease |
title_full | Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease |
title_fullStr | Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease |
title_full_unstemmed | Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease |
title_short | Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease |
title_sort | immune cell activation in the cerebrospinal fluid of patients with parkinson's disease |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305582/ https://www.ncbi.nlm.nih.gov/pubmed/30619041 http://dx.doi.org/10.3389/fneur.2018.01081 |
work_keys_str_mv | AT schroderjensb immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease AT pawlowskimatthias immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease AT meyerzuhorstegerd immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease AT grosscatharinac immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease AT wiendlheinz immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease AT meuthsveng immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease AT rucktobias immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease AT warnecketobias immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease |